News
Walgreens will pay up to $350M in settlement with DOJ to resolve opioid prescription lawsuit
Walgreens has agreed to pay $300 million to settle allegations from federal prosecutors that it illegally filled millions of invalid prescriptions for opioids and other controlled substances, the Department of Justice (DOJ) announced Monday.
Goldman Sachs Group Inc. is among about half a dozen Wall Street banks preparing to sell $4.25 billion of debt backing ...
Walgreens, which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit as the pharmacy chain operator benefited from a turnaround effort that ...
Pharmacy giant Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, which had ...
Walgreens Boots Alliance (NASDAQ: WBA) is in a pending acquisition with Sycamore Partners, a private equity firm, to take the ...
The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.
(Reuters) -Walgreens, which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit as the pharmacy chain operator benefited from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback